On July 21, 2020, the results of a proteomics study by the Center for Solutions for ME/CFS was published by the journal PLoS ONE. Proteomics uses new technologies—that have become available in the last two decades—to precisely identify large numbers of proteins and measure their levels. The measurement is…
By Dr. Anthony Komaroff Will some people who get COVID-19 subsequently develop ME/CFS? After all, many people with ME/CFS say that their illness began with some kind of infection: “a virus,” “a flu,” “a bad cold.” When it started, their illness didn’t feel that different from similar illnesses in the past, so no tests wereContinue reading “Will There Be a Post-COVID-19 Form of ME/CFS?”
Find links to the following applications below: Link to R01 Link to R21
The following is a transcript of Dr. Lipkin’s talk at the CDC in September. You can watch the full lecture here: Transcript 21:19 This is actually how I got into this field, I was invited by Brian Mahy, who many of you will remember, and Jim Dobbins who some of you may remember, because ofContinue reading “A microbe hunter turns to ME/CFS: Ian Lipkin presents at the CDC”
The following is a summary of the trans-NIH ME/CFS working group call from March 17, 2020. For a transcript of the call please visit the NIH webpage here. Beginning the call, Joe Breen, PhD highlighted various updates from our Collaborating Research Centers (CRC) at JAX labs, Cornell University, and our data managing site, RTI. AlsoContinue reading “ME/CFS Advocacy Call Highlights”
March 17, 202011:00 a.m. – 12:00 p.m. ETDial-in: 800-619-8524Participant passcode: 4213862 For a summary of the call, click here.
In December 2019, we asked our audience to send us questions they would want a ME/CFS expert to answer. Here are some of the questions we received from the community: